James Todd Auman

James Todd Auman

UNVERIFIED PROFILE

Are you James Todd Auman?   Register this Author

Register author
James Todd Auman

James Todd Auman

Publications by authors named "James Todd Auman"

Are you James Todd Auman?   Register this Author

4Publications

41Reads

28Profile Views

Genomic-derived markers for early detection of calcineurin inhibitor immunosuppressant-mediated nephrotoxicity.

Toxicol Sci 2011 Nov 24;124(1):23-34. Epub 2011 Aug 24.

Environmental Stress and Cancer Group, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/toxsci/kfr217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196657PMC
November 2011

Identification and replication of loci involved in camptothecin-induced cytotoxicity using CEPH pedigrees.

PLoS One 2011 May 5;6(5):e17561. Epub 2011 May 5.

Division of Pharmacotherapy and Experimental Therapeutics, Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0017561PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088663PMC
May 2011

Colorectal cancer cell lines lack the molecular heterogeneity of clinical colorectal tumors.

Clin Colorectal Cancer 2010 Jan;9(1):40-7

UNC Institute of Pharmacogenomics and Individualized Therapy, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CCC.2010.n.005DOI Listing
January 2010

Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation.

Eur J Cancer 2008 Aug 22;44(12):1754-60. Epub 2008 Jul 22.

UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, Chapel Hill, NC 27599-7360, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2008.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566790PMC
August 2008